Cipla Ltd. — Capital/Financing Update 2020

Aug 19, 2020

==> picture [101 x 36] intentionally omitted <==

Date: 19 August 2020

(1) BSE Ltd (2) National Stock Exchange of India Ltd Listing Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087

Scrip Code: CIPLA EQ

• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sirs,

Sub- Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), 2015

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we hereby notify that as a part of over-all group simplification process, the Company’s wholly owned subsidiary (WOS) Cipla Medpro South Africa Proprietary Limited (CMSA) has signed an agreement with Regipharm Medical Proprietary Limited, South Africa, to sell its entire equity stake in Anmaraté Proprietary Limited, South Africa, WOS of CMSA. Subsequent to the sale, Anmaraté Proprietary Limited will cease to be a subsidiary of the Company.

Anmaraté Proprietary Limited is a dormant step-down wholly owned subsidiary of the Company and does not carry out any operation.

A detailed disclosure as required under the Listing Regulations is enclosed as Annexure- I.

Thank you,

For Cipla Limited

Digitally signed by RAJENDRA CHOPRA DN: c=IN, o=Personal, RAJENDR 2.5.4.20=4987ad48c3965cfde78c8ea69e6f40ac91535876f12ba1fa5ba45cc5cc8db6cb, postalCode=122001, st=HARYANA, serialNumber=0be85c0408d0e3afd663669f 5314248a72fdcdf34d01d48d472d7cf92626 A CHOPRA 96f6, cn=RAJENDRA CHOPRA Date: 2020.08.19 23:38:34 +05'30'

_________________________

Rajendra Chopra Company Secretary

Enclosed:

1. Details as per the Listing Regulations

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai 400013, India. Phone : +91 2224826000 Fax : +9122 24826120 Website: www.cipla.com Email : contactus@cipla.com Corporate Identity Number: L24239MH1935PLC002380

==> picture [101 x 36] intentionally omitted <==

Annexure - I

Sale of equity stake in Anmaraté Proprietary Limited

Sr. No.	Particulars		Details
a)	The amount and percentage of the turnoveror revenue or income and net worthcontributed by such subsidiary of theCompany during the last financial year		As on March 31, 2020: Total Net Worth = ZAR 546,393 and Percentageof Net worth contributed = ~0.001% of CiplaLimited’ consolidated Networth Total Income = ZAR 2,187 and Percentage ofIncome contributed = 0.000006% of CiplaLimited’s consolidated turnover.However, as on the signing date, both income andnet worth are NIL.
b)	Date on which the agreement for sale hasbeen entered into		August 19, 2020
c)	The expected date of completion ofsale/disposal		August 31, 2020
d)	Considerationreceivedfromsuchsale/disposal;		ZAR 150,000
e)	Brief details of buyers and whether any of thebuyers belong to the promoter/ promotergroup /group companies. If yes, detailsthereof		Regipharm Medical Proprietary Ltd., (Buyer) is acompany incorporated under the laws of SouthAfrica with registration number 2014/052625/07.The Buyer runs a pharmaceutical regulationconsultancy in South Africa.Buyerdoesnotbelongtopromotergroup/promotergroupcompanies
f)	Whether the transaction would fall withinrelated party transactions? If yes, whetherthe same is done at “arm’s length”		No
g)	Additionally, in case of a slump sale,indicativedisclosuresprovidedforamalgamation/merger, shall be disclosed bythe Company with respect to such slump sale		Not Applicable

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai 400013, India. Phone : +91 2224826000 Fax : +9122 24826120 Website: www.cipla.com Email : contactus@cipla.com Corporate Identity Number: L24239MH1935PLC002380